サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1356793

急性虚血性脳卒中診断市場レポート：2030年までの動向、予測、競合分析

Acute Ischemic Stroke Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

急性虚血性脳卒中診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

急性虚血性脳卒中診断の動向と予測

世界の急性虚血性脳卒中診断市場は、2024年から2030年までのCAGRが7.2%で、2030年までに推定30億米ドルに達すると予測されます。この市場の主な促進要因は、急性脳卒中患者の増加、脳卒中に対する意識の高まり、診断機器や手術機器の技術革新です。世界の急性虚血性脳卒中診断市場の将来は、コンピューター断層撮影、磁気共鳴画像、頸動脈超音波、脳血管撮影、心電図、心エコー検査の各市場における機会によって有望視されています。

急性虚血性脳卒中診断市場の洞察

Lucintelでは、予測期間中もコンピュータ断層撮影が最大セグメントであり続けると予測しています。

北米は、政府のイニシアチブの増加、継続的な技術の進歩、虚血性脳卒中関連製品に対する需要の高まりにより、予測期間中も最大地域であり続けるでしょう。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の急性虚血性脳卒中診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の急性虚血性脳卒中診断市場動向（2018～2023年）と予測（2024～2030年）
  • 診断タイプ別の世界の急性虚血性脳卒中診断市場
    • コンピュータ断層撮影
    • 磁気共鳴画像
    • 頸動脈超音波検査
    • 脳血管造影
    • 心電図検査
    • 心エコー検査
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の急性虚血性脳卒中診断市場
  • 北米の急性虚血性脳卒中診断市場
  • 欧州の急性虚血性脳卒中診断市場
  • アジア太平洋急性虚血性脳卒中診断市場
  • その他地域急性虚血性脳卒中診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 診断タイプ別の世界の急性虚血性脳卒中診断市場の成長機会
    • 地域別の世界の急性虚血性脳卒中診断市場の成長機会
  • 世界の急性虚血性脳卒中診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の急性虚血性脳卒中診断市場の能力拡大
    • 世界の急性虚血性脳卒中診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Fujifilm Holdings
  • Samsung Electronics
  • GE Healthcare
  • Nihon Kohden
  • Canon Medical Systems
  • Koninklijke Philips NV
  • Siemens Healthineers
  • Mindray Medical International
  • Nanavati Super Speciality Hospital
  • Hoffmann-La Roche
目次

Acute Ischemic Stroke Diagnosis Trends and Forecast

The future of the global acute ischemic stroke diagnosis market looks promising with opportunities in the computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography markets. The global acute ischemic stroke diagnosis market is expected to reach an estimated $3.0 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are the growing number of acute stroke patients, rising awareness towards stroke, and technological innovations in diagnostic and surgical devices.

A more than 150-page report is developed to help in your business decisions.

Acute Ischemic Stroke Diagnosis by Segment

The study includes a forecast for the global acute ischemic stroke diagnosis by diagnostic type and region.

Acute Ischemic Stroke Diagnosis Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others

Acute Ischemic Stroke Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Acute Ischemic Stroke Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute ischemic stroke diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute ischemic stroke diagnosis companies profiled in this report include-

  • Fujifilm Holdings
  • Samsung Electronics
  • Ge Healthcare
  • Nihon Kohden
  • Canon Medical Systems
  • Koninklijke Philips Nv
  • Siemens Healthineers
  • Mindray Medical International
  • Nanavati Super Speciality Hospital
  • Hoffmann-La Roche

Acute Ischemic Stroke Diagnosis Market Insights

Lucintel forecasts that computed tomography will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to increasing government initiatives, ongoing technological advancements, and rising demand for ischemic stroke-related products.

Features of the Global Acute Ischemic Stroke Diagnosis Market

Market Size Estimates: Acute ischemic stroke diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute ischemic stroke diagnosis market size by diagnostic type, and region. in terms of value ($B).

Regional Analysis: Acute ischemic stroke diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic type, and region.s for the acute ischemic stroke diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute ischemic stroke diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the acute ischemic stroke diagnosis market size?

Answer: The global acute ischemic stroke diagnosis market is expected to reach an estimated $3.0 billion by 2030.

Q.2. What is the growth forecast for acute ischemic stroke diagnosis market?

Answer: The global acute ischemic stroke diagnosis market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the acute ischemic stroke diagnosis market?

Answer: The major drivers for this market are the growing number of acute stroke patients, rising awareness towards stroke, and technological innovations in diagnostic and surgical devices.

Q.4. What are the major segments for acute ischemic stroke diagnosis market?

Answer: The future of the acute ischemic stroke diagnosis market looks promising with opportunities in the computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography markets.

Q.5. Who are the key acute ischemic stroke diagnosis market companies?

Answer: Some of the key acute ischemic stroke diagnosis companies are as follows:

  • Fujifilm Holdings
  • Samsung Electronics
  • GE Healthcare
  • Nihon Kohden
  • Canon Medical Systems
  • Koninklijke Philips NV
  • Siemens Healthineers
  • Mindray Medical International
  • Nanavati Super Speciality Hospital
  • Hoffmann-La Roche

Q.6. Which acute ischemic stroke diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that computed tomography will remain the largest segment over the forecast period.

Q.7. In acute ischemic stroke diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, ongoing technological advancements, and rising demand for ischemic stroke-related products.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the acute ischemic stroke diagnosis market by diagnostic type (computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Ischemic Stroke Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Acute Ischemic Stroke Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Acute Ischemic Stroke Diagnosis Market by Diagnostic Type
    • 3.3.1: Computed Tomography
    • 3.3.2: Magnetic Resonance Imaging
    • 3.3.3: Carotid Ultrasound
    • 3.3.4: Cerebral Angiography
    • 3.3.5: Electrocardiography
    • 3.3.6: Echocardiography
    • 3.3.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Acute Ischemic Stroke Diagnosis Market by Region
  • 4.2: North American Acute Ischemic Stroke Diagnosis Market
  • 4.3: European Acute Ischemic Stroke Diagnosis Market
    • 4.3.1: European Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others
  • 4.4: APAC Acute Ischemic Stroke Diagnosis Market
    • 4.4.1: APAC Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others
  • 4.5: ROW Acute Ischemic Stroke Diagnosis Market
    • 4.5.1: ROW Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Acute Ischemic Stroke Diagnosis Market by Diagnostic Type
    • 6.1.2: Growth Opportunities for the Global Acute Ischemic Stroke Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Acute Ischemic Stroke Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Acute Ischemic Stroke Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Ischemic Stroke Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Fujifilm Holdings
  • 7.2: Samsung Electronics
  • 7.3: GE Healthcare
  • 7.4: Nihon Kohden
  • 7.5: Canon Medical Systems
  • 7.6: Koninklijke Philips NV
  • 7.7: Siemens Healthineers
  • 7.8: Mindray Medical International
  • 7.9: Nanavati Super Speciality Hospital
  • 7.10: Hoffmann-La Roche